Dove
- Manufacturer
- Conopco d/b/a Unilever
- Effective date
- 2026-03-30
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 01:52:01
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
DESCRIPTION SECTION
Dove Bridgerton Raspberry Rendezvous Raspberry Rose Tarte Antiperspirant Deodorant
OTC - ACTIVE INGREDIENT SECTION
Aluminum Sesquichlorohydrate 12.8%
OTC - PURPOSE SECTION
Antiperspirant
INDICATIONS & USAGE SECTION
reduces underarm wetness
WARNINGS SECTION
• For external use only. • Do not use on broken skin. • Ask a doctor before use if you have kidney disease. • Stop use if rash or irritation occurs. • If swallowed,get medical help or contact a Poison Control Center right away.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
• KEEP OUT OF REACH OF CHILDREN.
DOSAGE & ADMINISTRATION SECTION
apply to underarms only
INACTIVE INGREDIENT SECTION
Cyclopentasiloxane, Stearyl Alcohol, C12-15 Alkyl Benzoate, PPG-14 Butyl Ether, Hydrogenated Castor Oil, Glycine, PEG-8,
Calcium Chloride, Fragrance (Parfum), Dimethicone, Polyethylene, Silica, Hydroxystearic Acid, Helianthus Annuus (Sunflower) Seed Oil, Steareth-100, Stearic Acid, BHT, Alpha-Isomethyl Ionone, Benzyl Alcohol, Coumarin, Hexyl Cinnamal, Limonene, Linalool
OTC - QUESTIONS SECTION
Call 1-800-761-3683
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0079400531315 | GTIN-13: 0079400531315 EAN-13: 0079400531315 GTIN-12: 079400531315 UPC-A: 079400531315 GTIN storage (14 digits): 00079400531315 | Dove Bridgerton Raspberry Rendezvous Raspberry Rose Tarte Antiperspirant Deodorant - Artwork.jpg |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2 | Product name | 5 | 20250304 |
| 444b3e50-f226-46ef-bfca-2e7035d140cd | Product name | 1 | 20190611 |
| 7cda52fc-125f-421c-8fea-bc1974370c49 | Product name | 2 | 20180703 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 0ca1d589-929b-4b33-bc5b-1d84abdafa6a | Product name | 1 | 20150324 |
| fc363c46-397b-4476-ac0f-70e43e8e4592 | Product name | 1 | 20150324 |
| 87711080-88eb-65c5-b2dd-bf99e700a372 | Product name | 1 | 20140508 |
| ec2149b3-5c6d-5344-f757-c86411073075 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64942-2439-1 | Dove | 74 g in 1 CONTAINER | STICK | 74 | 1 |
Products#
Every source-derived product name is available through these pages.
- Dove
- Bridgerton Raspberry Rendezvous Raspberry Rose Tarte Antiperspirant Deodorant
- DIMETHICONE
- CALCIUM CHLORIDE
- ALUMINUM SESQUICHLOROHYDRATE
- POLYETHYLENE
- STEARIC ACID
- ALPHA-ISOMETHYL IONONE
- HEXYL CINNAMAL
- LINALOOL
- HYDROXYSTEARIC ACID
- PEG-8
- SILICA
- CYCLOPENTASILOXANE
- PPG-14 BUTYL ETHER
- COUMARIN
- LIMONENE, (+)-
- C12-15 ALKYL BENZOATE
- HYDROGENATED CASTOR OIL
- GLYCINE
- HELIANTHUS ANNUUS (SUNFLOWER) SEED OIL
- BENZYL ALCOHOL
- BHT
- STEARYL ALCOHOL
- STEARETH-100
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 64942-2439 | 64942-2439-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Dove | BRIDGERTON RASPBERRY RENDEZVOUS RASPBERRY ROSE TARTE ANTIPERSPIRANT DEODORANT | Conopco d/b/a Unilever | 4e436646-9135-83fb-e063-6294a90a3e99 | 2026-03-30 | Warnings | 64942-2439-1 64942-2439 64942243901 4e436646-9136-83fb-e063-6294a90a3e99 4e436646-9135-83fb-e063-6294a90a3e99 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
